UK markets closed

Tiziana Life Sciences Ltd (TLSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8473+0.0572 (+7.24%)
As of 12:03PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 79.25M
Enterprise value 73.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.96
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.77

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-1.25%
S&P500 52-week change 322.64%
52-week high 31.2700
52-week low 30.4100
50-day moving average 30.5086
200-day moving average 30.6068

Share statistics

Avg vol (3-month) 3155.7k
Avg vol (10-day) 3605.5k
Shares outstanding 5100.31M
Implied shares outstanding 6100.31M
Float 861.41M
% held by insiders 138.03%
% held by institutions 10.78%
Shares short (15 Apr 2024) 4257.78k
Short ratio (15 Apr 2024) 44.98
Short % of float (15 Apr 2024) 40.42%
Short % of shares outstanding (15 Apr 2024) 40.26%
Shares short (prior month 15 Mar 2024) 4365.78k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22499:1000
Last split date 331 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-44.64%
Return on equity (ttm)-90.40%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.77M
Net income avi to common (ttm)-19.5M
Diluted EPS (ttm)-0.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.6M
Total cash per share (mrq)0.07
Total debt (mrq)353k
Total debt/equity (mrq)2.66%
Current ratio (mrq)3.85
Book value per share (mrq)0.13

Cash flow statement

Operating cash flow (ttm)-19.09M
Levered free cash flow (ttm)-10.88M